Abstract
The Association for Cancer Immunotherapy (CIMT) held its 18th annual meeting virtually due to the COVID-19 pandemic. Europe's largest specialty meeting on cancer immunology and immunotherapy research and development digitally connected over 800 researchers and clinical professionals. Along with plenary sessions, around 220 abstracts were presented online in eTalks format. The multidisciplinary program covered several topics on the cancer immunotherapy research area, with emphasis on cellular therapies (mainly CAR T and natural killer cells), the role of neoantigens and therapeutic vaccination, combination therapies, gut microbiota and its relationship with cancer immunotherapies, immunoguiding, and the role of tumor microenvironment, as well as some sessions on computational immunology and regulatory research. Furthermore, a crosstalk session was dedicated to COVID-19 and immuno-oncology. This report focuses on a selection of presentations covering treatment updates given during the conference. © 2021 Clarivate Analytics.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
